Jarushka Naidoo

Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), posted the following on X:

“Important paper on incidence and outcomes of molecular subtypes of EGFR+ NSCLC in JTO and JTO CRR.

– 5,212 patients with EGFR+ NSCLC.
– 8.9% had uncommon EGFR mutations.
– Median time on TKIs 4.1m vs 10.9m (common) and 12.4m (compound).

Congratulations Alfredo Addeo et al.”

Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer.

Authors: Daniele Tavernari, Maxime Borgeaud, Ximeng Liu, Parikh Kaushal, Xiuning Le, Giovanni Ciriello, Alfredo Addeo

Jarushka Naidoo

Alfredo Addeo Beaumont Hospital cancer Daniele Tavernari EGFR+ NSCLC Giovanni Ciriello Jarushka Naidoo JTO and JTO CRR Maxime Borgeaud OncoDaily Oncology Parikh Kaushal Ximeng Liu Xiuning Le